Why is the Magnis (ASX:MNS) share price leaping 10% today?

Magnis shares are ending the week strongly…..

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Magnis shares are ending the week on a strong note.
  • This follows the release of an update on its majority owned iM3NY Battery Plant.
  • This plant will be North America’s largest home-grown factory in the global Li-ion battery cell manufacturing market once constructed.

The Magnis Energy Technologies Ltd (ASX: MNS) share price is having a strong finish to the week.

In afternoon trade, the vertically integrated lithium-ion battery company's shares are up 10% to 48 cents.

Green arrow going up on stock market chart, symbolising a rising share price.

Image source: Getty Images

Why is the Magnis share price shooting higher?

Investors have been bidding the Magnis share price higher today in response to the release of a positive announcement.

That release included an update on activities at the iM3NY Battery Plant based in Endicott, New York. Magnis is the major shareholder of the project.

According to the release, the overall project completion rate was 63% at the end of February.

This follows the Imperium team collaborating with EPC contractor Ramboll throughout the period and completing several mechanical, civil and electrical works. Progress was also made on several key items, with two new hires made during the month and vacancies for another eleven new positions.

What is the iM3NY Battery Plant?

Once constructed, the iM3NY Battery Plant has aggressive plans to scale up to 32GWh of annual production by 2030.

This will make it North America's largest home-grown factory in the global Li-ion battery cell manufacturing market. It will also be the only non-China supplier capable of meeting both domestic and global demand.

Management commentary

iM3NY's CEO, Chaitanya Sharma, commented: "We are working around the clock to meet our target which is on track to begin fully automated production in the next quarter. Potential customers and investors are coming in every week and discussions keep progressing."

Magnis' Chairman, Frank Poullas, added: "The shortage of cells in the marketplace continues to grow coupled with the increases in nickel and cobalt prices, timing could not be better for production in 2022."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

5 mini houses on a pile of coins.
Opinions

2 ASX shares I'd much rather buy than an investment property

Certain ASX shares can offer exposure to real estate with more income potential.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A businessman wears armour and holds a shield and sword.
Share Market News

Nervous investors turn to ASX 200 defensives as global energy shock drags on

ASX investors sought safety in defensive sectors last week.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Share Market News

How much do I need to invest in ASX shares to earn a $500 monthly passive income?

A $500 per month passive income is more achievable than you'd think.

Read more »